Medik8 receives investment to expand business
Cosmeceutical skincare brand Medik8 has received investment from a private equity company in order to expand the business.
Mid-market private equity company Inflexion has invested an undisclosed amount in Pangaea Laboratories, Medik8’s parent company.
In recent years Medik8 has turned its focus to sustainability and ethical manufacturing, alongside continuing its science-based research and development of skincare products and enhancing its relationships with the professional beauty and aesthetic industries. Recent product launches include Sleep Glycolic and Crystal Retinal 20.
“Medik8’s science-based approach to skincare combined with its sustainability credentials make it an incredibly impressive business. We look forward to working closely with the whole team to scale the business further through enhancing their digital routes to market, and by supporting their continued innovation, new product launches and international expansion,” said Simon Turner, managing partner of Inflexion.
Medik8 founder Elliot Issacs commented: “In the last three years, the brand has experienced phenomenal growth as the skincare consumer has become more knowledgeable and moved towards science and ingredients.
“We are thrilled to be partnering with Inflexion who have the passion and expertise to help us accelerate the brand’s international ambitions. Crucially, Inflexion have been unwavering in their support for our amazing team and professional-led heritage. We could not be more excited about the future.”
